Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Life Sciences - November, 2005
35 articles
- Acacia Takes Aim At Hospitals With New Patent Portfolio
- Teva, Sandoz Launch At-Risk Versions of Pfizer Drug
- Preliminary Injunction Forces Medical Device Off Shelves
- Suit Challenges USPTO Decision On Biotech Dispute
- Pfizer Wins Lipitor Patent Challenge
- China To Revamp Intellectual Property Laws: Report
- Robins Kaplan Hires Former Medtronic Legal Honcho
- Mylan Failed To Prove Identical Ingredients: Abbott Suit
- Federal Circuit Upholds Injunction Vs. Teva, Ranbaxy
- Ulcer Drug Patents Spark Court Battle
- DNA Replication Suit Favors Invitrogen In Federal Circuit
- Roche, Gilead Reach Tamiflu Agreement
- J&J Faces New Challenge To Schizophrenia Drug
- J&J-Guidant Merger Spotlights Stent Patent Wars
- Sanofi-Aventis Must Allow News Site To Use Drug Name
- McDermott Snags NY IP Litigators From Morgan Lewis
- Drug Store Giants Challenged Over Generic Packaging
- Impax Opens New Front In Adderall Battle With Shire
- Tamoxifen Ruling Eases Hatch-Waxman Settlements
- Judge Bans Andrx, Ranbaxy Generic Versions Of Biaxin
- Israel Revamps Drug Patent Extension Policy
- AstraZeneca Sues Teva Over Seroquel Patent Challenge
- Amgen Sues Roche Over Anemia Treatment
- FTC Lawsuit Sends Barr Back To Court
- Authorized Generics Deal Cleared Of Antitrust Charges
- Charges Mount Against Guidant As J&J Deal Sours
- In A Twist, Generics Maker Says Pfizer Infringed Patent
- Pfizer and Mylan Back To Court In Lengthy Dispute
- IP Litigation Awards, Settlements Reach Record Highs
- ImClone Stockholders Settle Insider Trading Charges
- Supreme Court May Co-Opt Patent Reform
- Drug Makers Gear Up For Round Two In Lipitor Case
- Chief Justice Drops Out Of Landmark Patent Case
- Supreme Court Mulls Case On Authorized Generics
- Novartis Purchase Of Chiron Puts Spotlight On Biologics